Subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome successfully treated with cyclosporin A.

A 17-year-old girl previously in good health presented with a 2-month history of recurrent, high-grade fever; general fatigue; anorexia; a 10-kg weight loss; and multiple, painful, reddish skin lesions on the lower abdomen. Some lesions were ulcerated, with an oily yellowish brown discharge. A systemic review was unremarkable other than bleeding from the nose. Her medical and family histories were unremarkable. On examination, the patient was pale, jaundiced, and febrile (temperature of 39 degrees C). She had enlarged lymph nodes in the axillary and inguinal areas. There was moderate hepatosplenomegaly. Local skin examination revealed multiple erythematous, tender, and firm subcutaneous nodules of variable size (1-2 cm) on the lower abdomen. Some nodules were ulcerated, with oily yellowish brown discharge and overlying ecchymosis (Figures 1 and 2). Mucous membranes were free of lesions. Laboratory investigations showed pancytopenia, an elevated erythrocyte sedimentation rate (>80 mm/h), normal renal function tests, abnormal hepatic function tests (alanine aminotransferase 172 U/L, aspartate aminotransferase 229 U/L, alkaline phosphatase 725 U/L, and total bilirubin 100 mmol/L [normal range 0-18 mmol/L]), conjugated bilirubin 45 mmol/L (normal range 0-5 mmol/L), and high triglycerides 855 mg/dL (normal range 20-200 mg/dL). Prolonged prothrombin time, 26 seconds (normal range 13-16 seconds); prolonged activated partial thromboplastin time, 61 seconds (normal range 26-38 seconds); positive disseminated intravascular coagulation studies evidenced by low fibrinogen, 74 mg/dL (normal range 160-350 mg/dL); and positive fibrinogen degradation products were also noted. Throat, midstream urine, and blood culture results were negative. Serologic tests for syphilis, HIV, and hepatitis B and C viruses were negative. Epstein-Barr virus and cytomegalovirus serologic values revealed evidence of past infection. Tuberculin and Coombs tests were negative. The alpha1-antitrypsin level was normal. Antinuclear and anti-smith antibodies, rheumatoid factor, and cryoglobulins were negative. CT showed enlarged lymph nodes in the axillary and inguinal areas, bilateral small pleural effusion, moderate hepatosplenomegaly, severe fatty infiltration of the liver, and thickening of lower abdominal subcutaneous tissue. A liver biopsy showed steatohepatitis. Bone marrow aspirate and trephine were normal. A deep punch biopsy of a nodule from the right lower abdomen revealed lobular panniculitis with atypical lymphocytes and large macrophages with cytophagocytosis ("beanbag" cells) (Figures 3 and 4). Immunohistochemistry showed that these atypical cells were positive for CD3, CD8, granzyme B, and perforin, and negative for CD56. T-cell gene rearrangement studies on skin lesions revealed a monoclonal T-cell receptor (gamma-chain) gene rearrangement, supporting the diagnosis of subcutaneous panniculitis-like T-cell lymphoma. On presentation, the initial treatment included 6 U of fresh frozen plasma, 2 U of packed red blood cells, and 2 g IV fibrinogen for 3 consecutive days. The patient was started on prednisolone 60 mg orally once daily and cyclosporine A 5 mg/kg/d orally in two divided doses. The fever and other systemic symptoms and skin lesions resolved within 2 weeks after the treatment. The prednisolone dose was tapered gradually, and a maintenance dose of cyclosporine A was continued. The patient's condition remained in remission at 12-month follow-up; there was no evidence of clinical relapse.

[1]  B. Bandarchi,et al.  Fatal subcutaneous panniculitis‐like T‐cell lymphoma with interface change and dermal mucin, a dead ringer for lupus erythematosus , 2005, Journal of cutaneous pathology.

[2]  S. Wester,et al.  Immunophenotypic and molecular features, clinical outcomes, treatments, and prognostic factors associated with subcutaneous panniculitis‐like T‐cell lymphoma , 2004, Cancer.

[3]  R. Scolyer,et al.  Unusual case of subcutaneous panniculitis‐like T‐cell lymphoma , 2004, The Australasian journal of dermatology.

[4]  F. Gök,et al.  Fatal Cytophagic Histiocytic Panniculitis , 2004, Pediatric dermatology.

[5]  L. Török,et al.  Panniculitis‐like T‐cell lymphoma clinically manifested as alopecia , 2002, The British journal of dermatology.

[6]  J. Snow,et al.  Subcutaneous panniculitic T‐cell lymphoma and cytophagic histiocytic panniculitis , 2001, The Australasian journal of dermatology.

[7]  N. Nemoto,et al.  Phagocytized apoptotic cells in subcutaneous panniculitis‐like T‐cell lymphoma , 2001, Journal of the European Academy of Dermatology and Venereology : JEADV.

[8]  T. Okamura,et al.  Cytophagic histiocytic panniculitis--what is the best therapy? , 1999, Internal medicine.

[9]  H. Ohira,et al.  Cytophagic histiocytic panniculitis improved by combined CHOP and cyclosporin A treatment. , 1999, Internal medicine.

[10]  J. Guitart,et al.  Fatal cytophagic histiocytic panniculitis after a short response to cyclosporine. , 1998, Journal of the European Academy of Dermatology and Venereology : JEADV.

[11]  Fenton,et al.  Fatal cytophagic panniculitis and haemophagocytic syndrome , 1998, Clinical and experimental dermatology.

[12]  V. Tanphaichitr,et al.  Successful treatment of cytophagic histiocytic panniculitis by cyclosporin A: a case report. , 1997, Asian Pacific journal of allergy and immunology.

[13]  B. Athreya,et al.  Successful treatment of severe cytophagic histiocytic panniculitis with cyclosporine A. , 1996, Seminars in arthritis and rheumatism.

[14]  H. Blacklock,et al.  Treatment of cytophagic panniculitis with cyclosporin A. , 1992, American Journal of Medicine.